Medication info
Plarice Tablet (Clopidogrel Sulfate)

Plarice Tablet (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle, 30 tablets/box [(10 tablets/PPT x 3)]
Approval status
Active

MFDS item code 200501568 · Notified 2005.07.26 · Insurance code 647802630

Summary

Main use
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular events
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medicine is used to improve symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. Additionally, it alleviates atherosclerotic symptoms such as death, myocardial infarction, and stroke due to cardiovascular events in adult patients suffering from acute coronary syndrome or those who have undergone related procedures (PCI, CABG). In patients with atrial fibrillation who have vascular risk factors where the use of vitamin K antagonists is not suitable and the risk of bleeding is low, it helps to reduce the risk of stroke and thrombosis. This drug effectively reduces the risk of atherosclerosis and thrombosis associated with various cardiovascular diseases, thereby improving patient health.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This medicine is a drug that prevents platelets from aggregating, thereby preventing blood clotting. Individuals with genetically reduced function of a specific enzyme, CYP2C19, may experience reduced efficacy of this drug; in such cases, alternative treatment options should be considered. This drug may increase the risk of bleeding; therefore, it should not be used in patients with active bleeding or high bleeding risk, those with severe liver impairment, nursing mothers, and patients with genetic issues such as lactose intolerance. Patients at high risk for bleeding or those scheduled for surgery should stop or use this drug with caution, and extra care should be taken when combining it with other bleeding risk medications. While on this medication, patients should immediately consult their physician if any bleeding symptoms or adverse reactions occur, and regular blood tests should be conducted to monitor bleeding risks. Furthermore, this drug may interact with other medications, so caution is advised particularly when used with drugs that carry a risk of bleeding, specific antibiotics, gastric medications, antidepressants, morphine, etc. During pregnancy, it should only be used if necessary considering the potential effects on the fetus, and nursing women should carefully decide about stopping breastfeeding or the medication as the drug may be transmitted through breast milk. Elderly patients or those with impaired kidney function may also have increased bleeding risk, requiring dose adjustments and careful monitoring of their condition. In case of overdose, bleeding time may be prolonged, and bleeding may occur, so immediate notification to healthcare providers is required, and platelet transfusion or other treatments may be necessary.

Side effects

Hemorrhage, gastrointestinal bleeding, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular bleeding, intracranial hemorrhage, major bleeding, minor bleeding, hemorrhagic stroke, thrombocytopenia, neutropenia, aplastic anemia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decrease in motor function, tremor, speech disorder, abnormal gait, hyperkinesia, ataxia, perceptual disturbances, insomnia, depression, forgetfulness, anxiety, confusion, cognitive disturbances, abnormal behavior, arthralgia, myalgia, low back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, purpura, bloody stool, thrombocytopenia, anemia, hypochromic anemia, leukemia, leukopenia, eosinophilia, visual disturbances, field defects, dry eyes, transient blindness, congestion, tinnitus, urinary dysfunction, polyuria, non-protein nitrogen increase, uremia, elevated blood urea nitrogen, hypoglycemia, hyperuricemia, elevated liver enzymes, ALT increase, liver dysfunction, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergy symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal bleeding due to ulcers, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, papular urticaria, erythematous skin rash, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, eczema, lichen planus, glomerulopathy, gynecomastia, fever, abnormal liver function tests, elevated blood creatinine, cholecystitis, hematemesis, spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to ensure the drug's efficacy is safely maintained.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle, 30 tablets/box [(10 tablets/PPT x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.